Synthesis and Biological Activity of Azolo[a]quinoxalines

This review covers published data (mostly from 2019–2025) on the synthesis and biological activity of azolo[a]quinoxalines, including pyrazolo-, imidazo- and triazolo-annelated systems. We highlight that most research efforts are directed toward the design of anticancer agents, with additional applications as Toll like receptor antagonists, monoamine oxidase inhibitors, opioid receptor modulators, PI3Kα inhibitors, tubulin polymerization inhibitors, GABAᴀ receptor modulators, VEGFR 2 kinase inhibitors, BRD9 binders, and anti inflammatory, antimicrobial, and antifungal agents. Recent synthetic strategies include Cu catalyzed oxidative annulations, I₂ mediated C–H functionalization, metal free cascade cyclization, and multicomponent reactions, often employing eco friendly catalysts and reductants. A growing number of studies integrate virtual screening, molecular docking, and pharmacophore based in silico approaches to guide lead discovery and optimization. Innovative drug delivery systems, such as nanogels, and hybrid molecules combining azoloquinoxalines with pharmacophores like thalidomide have also been explored. This review emphasizes both the medicinal chemistry aspects of azolo[a]quinoxalines and the synthetic methodologies for their preparation, in the perspective of drug development and discovery.